No Data
Bloomage Biotechnology Corporation Limited specifically criticized nine brokerages, stating that "true innovation never fades in the torrent of time."
Sina Technology reported on the afternoon of May 21st that Bloomage Biotechnology Corporation Limited recently published an article on its official WeChat account titled "The Concept Always Replays, Technology Moves Forward Forever," refuting current market viewpoints such as "hyaluronic acid (commonly known as hyaluronic acid) is outdated." In this article, Bloomage Biotechnology directly names nine brokerage firms that have published Research Reports, including Sinolink, HTSC, Founder Securities, Ping An Securities, Western Securities, Anxin Securities, Shenwan Hongyuan Securities, Sinolink Securities, and Huafu Securities, stating that the rise of the "hyaluronic acid is outdated theory" is essentially an illusion created by "impatient capital constructing a thematic illusion." Bloomage Biotechnology emphasizes that hyaluronic acid is
Express News | West Securities Co., Ltd. has given Xiangcai Co., Ltd. an initial rating of buy.
Western Securities (002673.SZ): As of April 30, the company had a loan balance of 51.558 billion yuan.
On May 9, Gelonghui reported that Western Securities (002673.SZ) announced that as of December 31, 2024, the company's audited net Assets amounted to RMB 29.015 billion, and the loan balance was RMB 36.998 billion. As of April 30, 2025, the company's loan balance was RMB 51.558 billion, with a total of new loans of RMB 14.56 billion, accounting for 50.18% of last year's net Assets, exceeding 40%.
Express News | In May, the top stocks revealed had increases exceeding 3344%, with 11 stocks doubling their performance.
West Securities (002673) 2024 annual report review: all Business aspects have improved.
Item: Western Securities released the 2024 annual report. Total operating income excluding Other business revenue: 4.2 billion yuan, +10.5% year-on-year, with a quarterly figure of 1.6 billion yuan, up by 1.04 billion yuan quarter-on-quarter. Net income attributable to shareholders: 1.4 billion yuan.
Western Securities 2024 Profit Rises 20%, Revenue Slips 2.6%
